Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Lopez-Campos

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Genitourinary Cancer|December 18, 2021
Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-AnalysisAlejo Rodriguez-Vida, Andrés Rodríguez-Alonso, Eduardo Useros-Rodríguez, et al.
European Urology Oncology|September 30, 2025
Apalutamide in Patients with High Burden of Metastatic Hormone-sensitive Prostate Cancer: A Subgroup Analysis of TITANAlejo Rodriguez-Vida, Angel Borque, Fernando Lopez-Campos, et al.
Cancers|May 11, 2024
Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in SpainDaniela Gonsalves, Abrahams Ocanto, Eduardo Meilan, et al.
BMC Cancer|December 1, 2019
Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter studyDirk Rades, Olfred Hansen, Lars Henrik Jensen, et al.
European Urology Oncology|April 3, 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate CancerMatthew P Deek, Philip Sutera, Yuezhou Jing, et al.
Biomedicines|October 29, 2025
First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective StudyDaniela Gonsalves, Abrahams Ocanto, Eduardo Meilan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2023
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriersRebeca Lozano, Elena Castro, Fernando Lopez-Campos, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Genitourinary Cancer|December 18, 2021
Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-AnalysisAlejo Rodriguez-Vida, Andrés Rodríguez-Alonso, Eduardo Useros-Rodríguez, et al.
European Urology Oncology|September 30, 2025
Apalutamide in Patients with High Burden of Metastatic Hormone-sensitive Prostate Cancer: A Subgroup Analysis of TITANAlejo Rodriguez-Vida, Angel Borque, Fernando Lopez-Campos, et al.
Cancers|May 11, 2024
Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in SpainDaniela Gonsalves, Abrahams Ocanto, Eduardo Meilan, et al.
BMC Cancer|December 1, 2019
Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter studyDirk Rades, Olfred Hansen, Lars Henrik Jensen, et al.
European Urology Oncology|April 3, 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate CancerMatthew P Deek, Philip Sutera, Yuezhou Jing, et al.
Biomedicines|October 29, 2025
First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective StudyDaniela Gonsalves, Abrahams Ocanto, Eduardo Meilan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2023
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriersRebeca Lozano, Elena Castro, Fernando Lopez-Campos, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Pageof 2